Laptop computer showing pharmaceutical webinar on screen

Image source: Royal Pharmaceutical Society

Sponsored • Live webinar

The start of a new chapter for Martindale: The Complete Drug Reference

Watch live on: 9th July 2024
Starts: 11:00 BST (10:00 UTC, 15:00 PDT)
Duration: 1 hour


Health and industry professionals globally rely on Martindale: The Complete Drug Reference for concise and specific detail to identify and understand drugs, herbals, and other pharmaceutical substances. 

In this live webinar, hosted by Account Manager Morgane Brun, Catherine Cadart, and Alison Brayfield, co-editors of Martindale: The Complete Drug Reference will discuss the evolution of Martindale: The Complete Drug Reference, including a live demonstration on MedicinesComplete.

During this webinar you will:

  • Learn about the additional content that is available online 
  • See how to search intuitively
  • Find out about the links to other products on MedicinesComplete 



Speakers:

Catherine Cadart
Co-editor of Martindale: The Complete Drug Reference and Head of Content (Process and Performance) 

Alison Brayfield
Co-editor of Martindale: The Complete Drug Reference and Head of Content (Standards and Training) 


Source: Royal Pharmaceutical Society

04.07.2024

More on the subject:

Related articles

Photo

News • Ulterior motives in ad campaigns

Obesity: challenging the stigma – for the wrong reasons?

Drug companies campaign to destigmatize obesity. In principle, this is the right thing to do – but the commercial motives behind the message may put people's health at risk, experts argue.

Photo

News • Biobank-based study

Large dataset reveals hidden causes of side effects of medicines and vaccines

Why does the same medicine causes side effects in some people while others tolerate it well? In a new study, researchers utilized the Estonian Biobank to provide a more comprehensive picture.

Photo

News • Cardiovascular effects of bronchodilators

Asthma and COPD: Overuse of inhalers found to increase heart attack risk

Overuse of reliever inhalers is associated with higher risks of developing and dying from cardiovascular disease in asthma and COPD patients, according to a new study.

Subscribe to Newsletter